Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenhailong Capsule (深海龙胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical. It is a multi-ingredient formulation containing marine-derived components such as sea horse (*Hippocampus*) and pipefish (*Syngnathus*), along with herbal and animal-derived substances like ginseng (*Panax ginseng*), deer antler (*Cervus elaphus*), and epimedium. The capsule is indicated for tonifying the kidney, replenishing essence, and strengthening the body, specifically targeting symptoms of kidney-yang deficiency such as fatigue, dizziness, tinnitus, and sexual dysfunction (including impotence and premature ejaculation). It is approved and marketed in China as an over-the-counter (OTC) pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenhailong Capsule.